What was the YoY change in revenue and how much of it was organic versus acquisition driven? | ADUS (Aug 06, 2025) | Candlesense
ADUS

What was the YoY change in revenue and how much of it was organic versus acquisition driven?

Year‑over‑year (YoY) revenue change

  • Net service revenues for Q2 2025 were $349.4 million, which represents a 21.8 % increase compared with the same quarter in 2024.

Organic vs. acquisition‑driven growth

The press release you provided only reports the total YoY revenue growth (21.8 %). It does not break out how much of that increase came from “organic” growth (i.e., higher pricing, volume, or market‑share gains) versus how much was attributable to recent acquisitions.

Therefore, based on the information available in the news release, we can state the overall YoY revenue increase (21.8 %) but cannot quantify the portion that was organic versus acquisition‑driven. If you need that split, you would have to look for a more detailed earnings presentation, a supplemental footnote in the SEC filing (e.g., the 10‑Q), or a follow‑up commentary from management that specifically addresses the organic‑vs‑acquisition contribution.

Other Questions About This News

What is the company’s capital allocation plan—share buybacks, dividend increases, or reinvestment in growth—following this quarter’s performance? Are there any upcoming regulatory changes or reimbursement policy shifts that could affect future revenue or margins? How did the adjusted EBITDA margin change versus the prior quarter and year‑over‑year? How did the adjusted net income per diluted share growth (10.4%) compare to the growth of net service revenue (21.8%)? How did the reported earnings per share compare to analyst consensus estimates? How does the cash flow from operations compare to the prior quarter and to the company’s cash conversion ratio target? Did the company provide revised guidance for FY 2025, and how does it compare to prior guidance and consensus expectations? How does Addus HomeCare’s revenue growth and margin profile compare with its main competitors in the home‑care sector? How sustainable is the 21.8% revenue growth given the company’s historical growth rates and market conditions? What are the key risks highlighted by management (e.g., staffing shortages, labor costs, or reimbursement pressure) that could affect future performance? What impact will the reported results have on the stock’s technical indicators (e.g., moving averages, volume trends) and likely short‑term price movement? What is the composition of the $43.9 million adjusted EBITDA (e.g., operating margin, depreciation, amortization, and non‑recurring items)? What is the current debt load and net leverage ratio after this quarter’s results? What is the expected impact on earnings per share in the next quarter and the full‑year outlook based on the current trajectory? What were the drivers behind the 21.8% revenue growth – new client acquisition, higher visit volume, or price increases?